Company Active LTD

Company profile

Stemnovate Limited

Your Drug Discovery Partner

Our mission is to accelerate drug discovery from decades to years and from months to days. Building the future, caring for both human and animal lives. We are StemnovateTM.

CRN
10140603
Founded
2016
Age
10

Overview

Legal name
STEMNOVATE LIMITED
Region
East of England
Registered address
MAIA BUILDING (270)
BABRAHAM RESEARCH CAMPUS
CAMBRIDGE
UNITED KINGDOM
CB22 3AT
Insolvency history
No

Company events

Reference milestones and recent Companies House filing stream events.

6 events
30 Jun
2027

Accounts due

Accounts Due

Next accounts due date

05 May
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

21 Apr
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Sep
2025

Accounts filed

Accounts

Last accounts made up date

29 Aug
2024

Change Registered Office Address Company With Date Old Address New Address

Address

AD01 | Transaction MzQzMzgwMzI2MWFkaXF6a2N4

Published 29 Aug 2024 11:31

22 Apr
2016

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2017
Funded years
2017
Age at first award
1 years

Projects

2017 Collaborative R&D Lead participant

'Liver on a chip' an advanced microfluidic in vitro model for liver toxicity & safety screening.

1 Oct 2017 to 31 Dec 2019

Awarded
£745,508
Total cost £1,065,012

One of the biggest challenge in drug discovery is figuring out which drug candidates are likely to harm the liver before testing the agents in humans. Owing to species specific differences in liver pathways, and limited physiologically relevant information from in vitro models silent hepatotoxic drugs get introduced into clinical trials, garnering huge fi...

Product types

Collaborative R&D